HIV in Mpumalanga: progress in treatment but testing challenges remain

Home
→
HSRC Research Outputs
→
Public
→
View Item

dc.date.accessioned	2024-12-02	en
dc.date.accessioned	2024-12-12T10:01:44Z
dc.date.available	2024-12-12T10:01:44Z
dc.date.issued	2024-12-12	en
dc.identifier.uri	http://hdl.handle.net/20.500.11910/23787
dc.description.abstract	The HSRC’s latest provincial HIV data revealed that in Mpumalanga, HIV prevalence among young men aged 15–24 was 1.5 times higher than among their female peers. The finding is striking, considering that adolescent girls and young women (AGYW) have long accounted for a disproportionate share of HIV infections in South Africa. At the Mpumalanga launch of findings from the HSRC’s 2022 national household HIV survey, stakeholders argued that successful AGYW interventions should be fully extended to boys in the same age group. Increasing uptake of HIV testing also emerged as a priority in the province.	en
dc.format.medium	Print	en
dc.subject	HIV INFECTIONS	en
dc.subject	MPUMALANGA PROVINCE	en
dc.subject	ANTIRETROVIRAL THERAPY (ART)	en
dc.subject	HIV TREATMENT	en
dc.title	HIV in Mpumalanga: progress in treatment but testing challenges remain	en
dc.type	Journal Article	en
dc.description.version	N/A	en
dc.ProjectNumber	N/A	en
dc.Volume	22(4)	en
dc.BudgetYear	2024/25	en
dc.ResearchGroup	Impact Centre	en
dc.SourceTitle	HSRC Review	en
dc.ArchiveNumber	9814714	en
dc.URL	https://datafiles.hsrc.ac.za/eRKC%20-%20Electronic%20%20Copies%20of%20Research%20Outputs/Journal%20Articles/9814714/9814714.pdf?ga=1	en
dc.PageNumber	39-43	en
dc.outputnumber	15371	en
dc.bibliographictitle	Teagle, A. (2024) HIV in Mpumalanga: progress in treatment but testing challenges remain. HSRC Review. 22(4):39-43.	en
dc.publicationyear	2024	en
dc.contributor.author1	Teagle, A.	en